AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 11 min read$NCSM

MCSHANE MICHAEL sold (to issuer) 48,778 shares of NCSM

MCSHANE MICHAEL sold (to issuer) 48,778 shares of NCS Multistage Holdings, Inc. (NCSM) on 2026-09-01.

Original reporting
SEC EDGAR · MCSHANE MICHAEL
Published Sep 1, 2026, 1:38 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 1, 2026, 1:40 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$NCSM
Neutral
high confidence
Mentioned
$NCSM
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NCSMNeutralLow
01

Why it matters

The sale reduces insider ownership to zero, but the lack of price data limits actionable insight.

02

Market read

Minor insider sell; unlikely to affect market perception or price.

03

What to watch

Potential hidden motivations for the sale are not disclosed.

Relevance 4/10Novelty 4/10Timing: filing date 2026-09-01

Background

Form 4 filings disclose insider transactions; directors often sell for personal liquidity.

Company-level read

Ticker impact

$NCSMNeutralHigh confidence
Context

Director Michael McShane sold 48,778 shares of NCS Multistage Holdings, reducing his holding to zero.

Expected impact

minimal impact, price likely unchanged

Evidence & confidence

The transaction size is modest and price is undisclosed, typical for a director exiting a position.

Market effects

Sector

None; the filing does not affect the broader sector.

Regional

None; limited to the issuer.

Global

Low; isolated insider transaction.

Counterpoint

What could challenge this read

If the director's exit signals concerns, a short‑term dip could be considered.

Key entities

  • Director
    Michael McShane

    Insider who sold his entire stake.

  • Company
    NCS Multistage Holdings, Inc.

    Issuer of the shares sold.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

NCSM insider trading history →

Related articles

SEP 21
$SIONMed

RA CAPITAL MANAGEMENT, L.P. (Kolchinsky Peter, Shah Rajeev M.) sold $21.8M of SION (indirect holdings)

RA CAPITAL MANAGEMENT, L.P. sold 3,448,811 indirectly-held shares of Sionna Therapeutics, Inc. (SION) at an average of $6.33 ($6.32–$7.46, $21.84M total) across 2 trades on 2026-09-17. Filed jointly with RA Capital Healthcare Fund LP (Director), RA Capital Nexus Fund, L.P. (Director), RA Capital Nexus Fund III, L.P. (Director), Kolchinsky Peter (Director) and Shah Rajeev M. (Director).

SEC EDGAR1 min